The initiative, which was announced in May, aims to support research using the company’s Codex multiplex tissue imaging platform for single-cell spatial phenotyping and analysis. The new members of I2 include the following people:
- Omer Bayraktar, PhD, Head of the Cellular Genetics Scientific Group at the Wellcome Sanger Institute
- Sami Farhi, PhD, Principal Investigator at the Broad Institute of MIT and Harvard
- David Gray, PhD, Scientific Director of Ascopix
- Sinem Saka, PhD, group leader at the European Molecular Biology Laboratory
- Sizun Jiang, PhD, Principal Investigator, Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center
- Ruixuan Gao, PhD, Assistant Professor, University of Illinois, Chicago
- Cezary Ciszewski, PhD, Technical Director at the University of Chicago
These researchers, who already have or are considering purchasing Codex systems, will be invited to collaborate with other I2 Akoya members and subject matter experts, according to the company. Akoya’s technology partners will offer additional application support for other specialized imaging platforms, such as confocal or super-resolution microscopes, as well as custom antibody panel content and design, a Akoya said.
In addition, network members will have the first access to preliminary Codex tools and can influence product strategy, according to Akoya.
Codex staining of a sample of human brain tissue reveals the presence of biomarkers that allow researchers to visualize cellular organization at the single cell level and may help identify potential symptoms of diseases such as Alzheimer’s disease . Biomarkers in this image include CD34 (magenta), GFAP (green), neuronal nuclei (red), and -synuclein (blue). Image courtesy of Akoya Biosciences.
Copyright Â© 2021 scienceboard.net